The historical rank and industry rank for Deciphera Pharmaceuticals's Days Inventory or its related term are showing as below:
DCPH'
s Days Inventory Range Over the Past 10 Years
Min: 721.8 Med: 1638.83 Max: 9272.62
Current: 1646.8
During the past 9 years, Deciphera Pharmaceuticals's highest Days Inventory was 9272.62. The lowest was 721.80. And the median was 1638.83.
DCPH's Days Inventory is ranked worse than 99.07% of 969
companies
in the Drug Manufacturers industry
Industry Median: 159.69
vs DCPH: 1646.80
Deciphera Pharmaceuticals's Days Inventory
declined
from Mar. 2023 (4,309.04) to Mar. 2024 (924.47).
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Deciphera Pharmaceuticals's Inventory Turnover for the
three
months ended in Mar. 2024 was 0.10.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Deciphera Pharmaceuticals's Inventory-to-Revenue for the
three
months ended in Mar. 2024 was 0.47.
Deciphera Pharmaceuticals Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Deciphera Pharmaceuticals's Days Inventory
For the Drug Manufacturers - Specialty & Generic subindustry, Deciphera Pharmaceuticals's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Deciphera Pharmaceuticals's Days Inventory Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Deciphera Pharmaceuticals's Days Inventory distribution charts can be found below:
* The bar in red indicates where Deciphera Pharmaceuticals's Days Inventory falls into.
Deciphera Pharmaceuticals Days Inventory Calculation
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Deciphera Pharmaceuticals's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Deciphera Pharmaceuticals (NAS:DCPH) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Deciphera Pharmaceuticals's Inventory Turnover for the
three
months ended in Mar. 2024 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Deciphera Pharmaceuticals's Inventory to Revenue for the
three
months ended in Mar. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Deciphera Pharmaceuticals Days Inventory Related Terms
Thank you for viewing the detailed overview of Deciphera Pharmaceuticals's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
Deciphera Pharmaceuticals (Deciphera Pharmaceuticals) Business Description
Deciphera Pharmaceuticals Inc is a biotechnology company, which develops and manufactures kinase-inhibiting drugs for the treatment of cancers and immunological diseases. It holds a diverse pipeline of drug candidates that includes three clinical-stage and two research-stage programs. Its lead drug candidate DCC-2618 is designed to inhibit the full spectrum of mutant or amplified KIT and Pdgfra kinases that drive cancers such as gastrointestinal stromal tumors, advanced systemic mastocytosis, gliomas, and other solid tumors. In addition, it is also developing two other clinical-stage drug candidates, DCC-3014 and Rebastinib. Geographically all the operations function through the region of the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
DCPH has been successfully added to your 